![Michael Catelani](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Catelani
Director of Finance/CFO at ANIXA BIOSCIENCES, INC.
Net worth: 117 605 $ as of 2024-08-30
Profile
Michael J.
Catelani was the founder of Tacere Therapeutics, Inc. (founded in 2006), where he held the title of Chairman, President & Chief Financial Officer from 2006 to 2012.
He is currently working at Anixa Biosciences, Inc. (since 2016) as President, COO, CFO & Secretary.
In his former positions, he served as Chief Financial Officer & Director at Benitec Biopharma Ltd.
(2005-2006), Treasurer & Director at InnVision the Way Home, Vice President-Finance at Media Arts Group, Inc. (1998-2001), Chief Financial Officer & Vice President at Axon Instruments, Inc. (2002-2004), and Controller, Project Manager-Research & Development at Airtox, Inc. He also held the title of Principal at Ernst & Young LLP (Missouri).
Mr. Catelani obtained an undergraduate degree from California State University-Sacramento and an MBA from the University of California, Davis.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ANIXA BIOSCIENCES, INC.
0.11% | 2024-06-06 | 35,211 ( 0.11% ) | 117 605 $ | 2024-08-30 |
Latest news about Michael Catelani
Michael Catelani active positions
| Companies | Position | Start |
|---|---|---|
| ANIXA BIOSCIENCES, INC. | Director of Finance/CFO | 2016-10-31 |
Former positions of Michael Catelani
| Companies | Position | End |
|---|---|---|
Tacere Therapeutics, Inc.
 Tacere Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tacere Therapeutics, Inc. provides treatment of infectious diseases. It develops novel therapeutics for the treatment of serious infectious diseases such as Hepatitis C (HCV). The company was founded by Sara M. Hall, Amit J. Kumar, John James Monahan, and Michael J. Catelani in 2006 and is headquartered in San Jose, CA. | Founder | 2012-09-30 |
Benitec Biopharma Ltd.
 Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | Director of Finance/CFO | 2006-06-21 |
Axon Instruments, Inc.
 Axon Instruments, Inc. Medical SpecialtiesHealth Technology Axon Instruments, Inc. manufactures instruments and software for drug discovery and academic research. The company is based in Union City, CA. Axon Instruments was acquired by Molecular Devices LLC, part of Danaher Corp. from March 28, 2007 on July 01, 2004 for $128.27 million. | Director of Finance/CFO | 2003-12-31 |
Media Arts Group, Inc.
 Media Arts Group, Inc. Home FurnishingsConsumer Durables Media Arts Group, Inc. designs, manufactures, and markets artistic products based on the works of artist Thomas Kinkade. The company is headquartered in San Jose, CA. | Director of Finance/CFO | 2000-12-31 |
| InnVision the Way Home | Director/Board Member | - |
Training of Michael Catelani
| California State University-Sacramento | Undergraduate Degree |
| University of California, Davis | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ANIXA BIOSCIENCES, INC. | Health Technology |
| Private companies | 7 |
|---|---|
Benitec Biopharma Ltd.
Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | Health Technology |
Tacere Therapeutics, Inc.
Tacere Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tacere Therapeutics, Inc. provides treatment of infectious diseases. It develops novel therapeutics for the treatment of serious infectious diseases such as Hepatitis C (HCV). The company was founded by Sara M. Hall, Amit J. Kumar, John James Monahan, and Michael J. Catelani in 2006 and is headquartered in San Jose, CA. | Health Technology |
Axon Instruments, Inc.
Axon Instruments, Inc. Medical SpecialtiesHealth Technology Axon Instruments, Inc. manufactures instruments and software for drug discovery and academic research. The company is based in Union City, CA. Axon Instruments was acquired by Molecular Devices LLC, part of Danaher Corp. from March 28, 2007 on July 01, 2004 for $128.27 million. | Health Technology |
Media Arts Group, Inc.
Media Arts Group, Inc. Home FurnishingsConsumer Durables Media Arts Group, Inc. designs, manufactures, and markets artistic products based on the works of artist Thomas Kinkade. The company is headquartered in San Jose, CA. | Consumer Durables |
Airtox, Inc.
 Airtox, Inc. Miscellaneous Commercial ServicesCommercial Services Airtox, Inc. provides creative, customized, defensible solutions for air testing. It offers fenceline monitoring, soil gas, vapor intrusion, ambient air monitoring, manufactured gas plant and method development services. The company was founded in 1989 and is headquartered in Folsom, CA. | Commercial Services |
Ernst & Young LLP (Missouri)
 Ernst & Young LLP (Missouri) Miscellaneous Commercial ServicesCommercial Services Ernst & Young provides accounting services. Its services include auditing, accounting, tax and transaction services, assurance and advisory business, online transaction advisory and a wide range of financial services. The company was founded by Arthur Young and Alwin C. Ernst in 1881 and is headquartered in Kansas City, MO. | Commercial Services |
| InnVision the Way Home | Health Services |
- Stock Market
- Insiders
- Michael Catelani